J9360 HCPCS code: Injection, vinblastine sulfate, 1 mg
J9360 is the HCPCS Level II code for injection, vinblastine sulfate, 1 mg. In 2024 Medicare paid an average of $3.38 per service for J9360 across 22,142 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 45 per day on DME suppliers. Medicare volume fell 14% from 2022 to 2024 (25,744 to 22,142 services). In 2024, about 665 clinicians billed Medicare for J9360 for 413 beneficiaries; Florida, Texas, California accounted for 47% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 1986-01-01 |
| Last action effective | 2009-01-01 |
Who bills J9360 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 665 |
| Medicare beneficiaries | 413 |
| States with claims | 15 |
| Share of services in top 3 states (Florida, Texas, California) | 47% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9360, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 25,744 | 498 | $3.90 | $3.11 |
| 2023 | 23,830 | 459 | $3.90 | $3.09 |
| 2024 | 22,142 | 413 | $4.25 | $3.38 |
States with the most J9360 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 3,114 | $3.41 |
| Texas | 2,236 | $3.51 |
| California | 2,045 | $3.46 |
| Illinois | 1,499 | $3.37 |
| New York | 1,250 | $3.42 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 45 | Clinical: CMS Workgroup |
| outpatient hospital claims | 40 | Prescribing Information |
| practitioner claims | 40 | Prescribing Information |
What changed for J9360
- 1986-01-01: J9360 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9360?
J9360 is the HCPCS Level II code for injection, vinblastine sulfate, 1 mg. Short descriptor: "Vinblastine sulfate inj".
How much does Medicare pay for J9360?
In 2024, the average Medicare payment was $3.38 per service (average allowed $4.25).
Does Medicare cover J9360?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J9360 can be billed per day?
45 on DME suppliers; 40 on outpatient hospital claims; 40 on practitioner claims (NCCI medically unlikely edits).
Related J93 codes
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg
- J9301 — Injection, obinutuzumab, 10 mg
- J9302 — Injection, ofatumumab, 10 mg
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9308 — Injection, ramucirumab, 5 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9360
- Watch J9360 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9360
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.